Gabriel Lima-Oliveira1, Giuseppe Lippi2, Gian Luca Salvagno3, Marise Danielle Raulino Campelo4, Katharyne Soares Adala Tajra4, Flavio dos Santos Gomes4, Carlos David Valentim4, Sylvio José Colonna Romano4, Geraldo Picheth5, Gian Cesare Guidi6. 1. Post-Graduate Programme of Pharmaceutical Sciences, Department of Medical Pathology, Federal University of Parana, Curitiba, Parana, Brazil Laboratory of Clinical Biochemistry, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy Clinical Laboratory Bioanalise, Teresina, Piaui, Brazil. 2. Department of Pathology and Laboratory Medicine, Clinical Chemistry and Haematology Laboratory, Academic Hospital of Parma, Parma, Italy. 3. Post-Graduate Programme of Pharmaceutical Sciences, Department of Medical Pathology, Federal University of Parana, Curitiba, Parana, Brazil. 4. Clinical Laboratory Bioanalise, Teresina, Piaui, Brazil. 5. Laboratory of Clinical Biochemistry, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy. 6. Post-Graduate Programme of Pharmaceutical Sciences, Department of Medical Pathology, Federal University of Parana, Curitiba, Parana, Brazil Laboratory of Clinical Biochemistry, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy.
Abstract
BACKGROUND: In vitro diagnostic tests play a key role in patients' management (e.g., guiding red blood cell transfusions). The aim of this study was to evaluate the impact of an innovative device (Buzzy®) which is claimed to be able to relieve venipuncture pain by means of cold and vibration. This device was applied during collection of venous blood by venipuncture for conventional haematology testing. MATERIALS AND METHODS: Blood was drawn from 100 volunteers by a single, expert phlebotomist. A vein was located in the left forearm without applying a tourniquet but using a subcutaneous tissue transilluminator device, so that venous stasis was avoided. Blood samples were collected with a 20G straight needle directly into 4 mL K3EDTA vacuum tubes. In sequence, external cold and vibration was established by Buzzy® on the right forearm -5 cm above the venipuncture site- for 1 minute before venipuncture and continued until the end of the same procedure already performed in the left forearm. Conventional haematological tests were performed using the same instrument (Sysmex® XE-2100D) in all cases. RESULTS: When Buzzy® was applied before drawing blood, erythrocyte counts and associated parameters (i.e., haemoglobin and haematocrit) were higher, whereas platelet number, leucocyte count and differential were lower. Statistically and clinically significant differences (P<0.001) were observed for erythrocytes, haemoglobin and haematocrit. DISCUSSION: From a practical perspective, cold-induced haemoconcentration promotes the efflux of water, diffusible ions and low molecular weight molecules from the vessel, thus increasing the concentration of other blood analytes at the puncture site. These variations may influence test results, especially for erythrocytes, haemoglobin and haematocrit. The novel Buzzy® device should, therefore, be used with caution when collecting blood for conventional haematological testing because of the observed bias introduced in some parameters.
BACKGROUND: In vitro diagnostic tests play a key role in patients' management (e.g., guiding red blood cell transfusions). The aim of this study was to evaluate the impact of an innovative device (Buzzy®) which is claimed to be able to relieve venipuncture pain by means of cold and vibration. This device was applied during collection of venous blood by venipuncture for conventional haematology testing. MATERIALS AND METHODS: Blood was drawn from 100 volunteers by a single, expert phlebotomist. A vein was located in the left forearm without applying a tourniquet but using a subcutaneous tissue transilluminator device, so that venous stasis was avoided. Blood samples were collected with a 20G straight needle directly into 4 mL K3EDTA vacuum tubes. In sequence, external cold and vibration was established by Buzzy® on the right forearm -5 cm above the venipuncture site- for 1 minute before venipuncture and continued until the end of the same procedure already performed in the left forearm. Conventional haematological tests were performed using the same instrument (Sysmex® XE-2100D) in all cases. RESULTS: When Buzzy® was applied before drawing blood, erythrocyte counts and associated parameters (i.e., haemoglobin and haematocrit) were higher, whereas platelet number, leucocyte count and differential were lower. Statistically and clinically significant differences (P<0.001) were observed for erythrocytes, haemoglobin and haematocrit. DISCUSSION: From a practical perspective, cold-induced haemoconcentration promotes the efflux of water, diffusible ions and low molecular weight molecules from the vessel, thus increasing the concentration of other blood analytes at the puncture site. These variations may influence test results, especially for erythrocytes, haemoglobin and haematocrit. The novel Buzzy® device should, therefore, be used with caution when collecting blood for conventional haematological testing because of the observed bias introduced in some parameters.
Authors: C Ricós; F Cava; J V García-Lario; A Hernández; N Iglesias; C V Jiménez; J Minchinela; C Perich; M Simón; M V Domenech; V Alvarez Journal: Scand J Clin Lab Invest Date: 2004 Impact factor: 1.713
Authors: Giuseppe Lippi; Antonella Bassi; Giorgio Brocco; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi Journal: Clin Chem Date: 2006-07 Impact factor: 8.327
Authors: Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi Journal: Indian J Clin Biochem Date: 2013-04-03
Authors: Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi Journal: Biochem Med (Zagreb) Date: 2012 Impact factor: 2.313